The purpose of this study is to evaluate the efficiency and toxicity of adjuvant hypofractionation radiotherapy for thymic epithelial tumours after complete resection.
Adjuvant Radiotherapy(Postoperative radiotherapy) is proposed in stage II and III thymic carcinoma，stage III thymoma，stage IIB B2/B3 thymomas. Hypofractionation Radiotherapy is used in this study. The purpose of this study is to evaluate the efficiency and toxicity of adjuvant hypofractionation radiotherapy for thymic epithelial tumours after complete resection.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
50
Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College
Beijing, Beijing Municipality, China
Disease Free Survival
From the date of resection to the date of disease recurrence or death
Time frame: 2 years, 5 years
Overall Survival
From the date of resection to the date of death
Time frame: 2 years, 5 years
RadiotherapyToxicity
Rate of pneumonitis；Rate of esophagitis；Rate of skin reaction；Rate of myelitis；Rate of heart disease；Rate of vascular toxicity
Time frame: 1 years, 2 years, 5 years
local recurrence
recurrence of tumor bed
Time frame: 2 years, 5 years
Intrathoracic recurrence / pleural metastasis
Rate of Intrathoracic recurrence / pleural metastasis
Time frame: 2 years, 5 years
metastasis free survival
From the date of resection to the date of metastasis or death
Time frame: 2 years, 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.